Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment

Ähnliche Einträge

• Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure
  von: Juliane Rascher, et al.
  Veröffentlicht: (2024)
• Probability of pharmacokinetic/pharmacodynamic target attainment for different piperacillin/tazobactam dosing regimens in renally impaired patients in a non‐intensive care unit setting
  von: Emma Dohmann, et al.
  Veröffentlicht: (2025)
• Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673
  von: Yue Wu, et al.
  Veröffentlicht: (2024)
• Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages
  von: Cheng‐jie Ke, et al.
  Veröffentlicht: (2025)
• The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat
  von: Chandrali S. Bhattacharya, et al.
  Veröffentlicht: (2024)